Annals of Surgical Oncology

, Volume 16, Issue 8, pp 2288–2294 | Cite as

A Prospective, Multi-Institutional Study of Adjuvant Radiotherapy After Resection of Malignant Phyllodes Tumors

  • Richard J. BarthJr.
  • Wendy A. Wells
  • Sandra E. Mitchell
  • Bernard F. Cole
Breast Oncology

Abstract

Background

Malignant phyllodes tumors of the breast are unusual neoplasms, with an incidence of approximately 500 cases annually in the United States. Published local recurrence rates after margin-negative breast-conserving resections of borderline malignant and malignant phyllodes tumors are unacceptably high, at 24 and 20%, respectively. It is uncertain whether radiotherapy after resection of phyllodes tumors is beneficial.

Methods

We prospectively enrolled patients who were treated with a margin-negative breast-conserving resection of borderline malignant or malignant phyllodes tumors to adjuvant radiotherapy. The primary endpoint was local recurrence.

Results

Forty-six women were treated at 30 different institutions. The mean patient age was 49 years (range, 18–76 years). Thirty patients (65%) had malignant phyllodes tumors; the rest were borderline malignant. The mean tumor diameter was 3.7 cm (range, .8–11 cm). Eighteen patients had a negative margin on the first excision. The median size of the negative margin was .35 cm (range, <.1–2 cm). Twenty-eight patients underwent a re-excision because of positive margins in the initial resection. Two patients died of metastatic phyllodes tumor. During a median follow-up of 56 months (range, 12–129 months), none of the 46 patients developed a local recurrence (local recurrence rate, 0%; 95% confidence interval, 0–8).

Conclusions

Margin-negative resection combined with adjuvant radiotherapy is very effective therapy for local control of borderline and malignant phyllodes tumors. The local recurrence rate with adjuvant radiotherapy was significantly less than that observed in reported patients treated with margin-negative resection alone.

References

  1. 1.
    SEER 17 data on phyllodes tumors. Available at: http://seer.cancer.gov/data. Accessed December 6, 2007
  2. 2.
    Reinfuss M, Mitus J, Duda K, et al. The treatment and prognosis of patients with phyllodes tumor of the breast. Cancer. 1996;77:910–6.PubMedCrossRefGoogle Scholar
  3. 3.
    Asoglu O, Ugurlu M, Blanchard K, et al. Risk factors for recurrence and death after primary surgical treatment of malignant phyllodes tumors. Ann Surg Oncol. 2004;11:1011–7.PubMedCrossRefGoogle Scholar
  4. 4.
    Belkacemi Y, Bousquet G, Marsiglia H, et al. Phyllodes tumors of the breast. Int J Radiat Oncol Biol Phys. 2008;70:492–500.PubMedGoogle Scholar
  5. 5.
    Macdonald O, Lee C, Tward J, Chappel C, Gaffney D. Malignant phyllodes tumor of the female breast. Cancer. 2006;107:2127–33.PubMedCrossRefGoogle Scholar
  6. 6.
    Barth R. Histologic features predict local recurrence after breast conserving therapy of phyllodes tumors. Breast Cancer Res Treat. 1999;57:291–5.PubMedCrossRefGoogle Scholar
  7. 7.
    World Health Organization. Histologic typing of breast tumors. Tumori. 1982;68:181–98.Google Scholar
  8. 8.
    de Roos W, Kaye P, Dent D. Factors leading to local recurrence or death after surgical resection of phyllodes tumors of the breast. Br J Surg. 1999;86:396–9.PubMedCrossRefGoogle Scholar
  9. 9.
    Zissis C, Apostolikas N, Konstantinidou A, Griniatsos J, Vassilopoulos P. The extent of surgery and prognosis of patients with phyllodes tumor of the breast. Breast Cancer Res Treat. 1998;48:205–10.PubMedCrossRefGoogle Scholar
  10. 10.
    Holthouse D, Smith P, Naunton-Morgan R, Minchin D. Cystosarcoma phyllodes: the western Australian experience. Aust N Z J Surg. 1999;69:635–8.PubMedCrossRefGoogle Scholar
  11. 11.
    Chaney A, Pollack A, Mcneese M, et al. Primary treatment of cystosarcoma phyllodes of the breast. Cancer. 2000;89:1502–11.PubMedCrossRefGoogle Scholar
  12. 12.
    Kapiris I, Nasir N, A’hern R, Healy V, Gui G. Outcome and predictive factors of local recurrence and distant metastases following primary surgical treatment of high-grade malignant phyllodes tumors of the breast. Eur J Surg Oncol. 2001;27:723–30.PubMedCrossRefGoogle Scholar
  13. 13.
    Kok K, Telesinghe P, Yapp S. Treatment and outcome of cystosarcoma phyllodes in Brunei: a 13 year experience. J R Coll Surg Edinb. 2001;46:198–201.PubMedGoogle Scholar
  14. 14.
    Fou A, Schnabel F, Hamele-Bena D, et al. Long term outcomes of malignant phyllodes tumors patients: an institutional experience. Am J Surg. 2006;192:492–5.PubMedCrossRefGoogle Scholar
  15. 15.
    Abdalla H, Sakr M. Predictive factors of local recurrence and survival following primary surgical treatment of phyllodes tumors of the breast. J Egypt Natl Canc Inst. 2006;18:125–33.PubMedGoogle Scholar
  16. 16.
    Taira N, Takabatake D, Aogi K, et al. Phyllodes tumor of the breast: stromal overgrowth and histological classification are useful prognosis-predictive factors for local recurrence in patients with a positive surgical margin. Jpn J Clin Oncol. 2007;37:730–6.PubMedCrossRefGoogle Scholar
  17. 17.
    Barrio A, Clark B, Goldberg J, et al. Clinicopathologic features and long term outcomes of 293 phyllodes tumors of the breast. Ann Surg Oncol. 2007;14:2961–70.PubMedCrossRefGoogle Scholar
  18. 18.
    Lenhard M, Kahlert S, Himsl I, et al. Phyllodes tumor of the breast: clinical follow-up of 33 cases of this rare disease. Eur J Obstet Gynecol Reprod Biol. 2007;138:217–21.PubMedCrossRefGoogle Scholar
  19. 19.
    Pietruszka M, Barnes L. Cystosarcoma phyllodes. Cancer. 1978;41:1974–83.PubMedCrossRefGoogle Scholar
  20. 20.
    Moffat C, Pinder S, Dixon A, et al. Phyllodes tumors of the breast: a clinicopathological review of 32 cases. Histopathology. 1995;27:205–18.PubMedCrossRefGoogle Scholar
  21. 21.
    Pezner R, Schultheiss T, Paz I. Malignant phyllodes tumor of the breast: local control rates with surgery alone. Int J Radiat Oncol Biol Phys. 2008;71:710–13.PubMedGoogle Scholar
  22. 22.
    Chen W, Cheng S, Tzen C, et al. Surgical treatment of phyllodes tumors of the breast: retrospective review of 172 cases. J Surg Oncol. 2005;91:185–94.PubMedCrossRefGoogle Scholar
  23. 23.
    Pandey M, Mathew A, Kattoor J, et al. Malignant phyllodes tumor. Breast J. 2001;7:411–6.PubMedCrossRefGoogle Scholar
  24. 24.
    Mangi A, Smith B, Gadd M, et al. Surgical management of phyllodes tumors. Arch Surg. 1999;134:487–93.PubMedCrossRefGoogle Scholar
  25. 25.
    Clark M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15 year survival: an overview of the randomized trials. Lancet. 2005;366:2087–106.Google Scholar
  26. 26.
    Hoover H, Testioreanu A, Ketcham A. Metastatic cystosarcoma phyllodes in an adolescent girl. Ann Surg. 1975;181:279–82.PubMedCrossRefGoogle Scholar
  27. 27.
    Burton G, Hart L, Leight G, et al. Cystosarcoma phyllodes, effective treatment with chemotherapy. Cancer. 1989;63:2088–92.PubMedCrossRefGoogle Scholar
  28. 28.
    Thomas A, Ashworth B, Blake P. Regression of recurrent cystosarcoma phyllodes tumor after neutron treatment. Br J Radiol. 1984;57:926–9.PubMedGoogle Scholar
  29. 29.
    Allen R, Nixon D, York M, et al. Successful chemotherapy for cystosarcoma phyllodes. Arch Intern Med. 1985;145:1127–8.PubMedCrossRefGoogle Scholar
  30. 30.
    Turalba C, El-Mahdi A, Ladga L. Fatal metastatic cystosarcoma phyllodes. J Surg Oncol. 1986;33:176–81.PubMedCrossRefGoogle Scholar
  31. 31.
    Stockdale A, Leader M. Case report: phyllodes tumor of the breast: response to radiotherapy. Clin Radiol. 1987;38:287.PubMedCrossRefGoogle Scholar
  32. 32.
    Lindquist K, van Heerden J, Wieland L, et al. Recurrent and metastatic cystosarcoma phyllodes. Am J Surg. 1982;144:341–3.PubMedCrossRefGoogle Scholar
  33. 33.
    Reinfuss M, Mitus J, Smolak K, Stelkmach A. Malignant phyllodes tumors of the breast. Eur J Cancer. 1993;29A:1252–6.Google Scholar
  34. 34.
    Joshi S, Sharma D, Bahadur A, et al. Cystosarcoma phyllodes: our institutional experience. Australas Radiol. 2003;47:434–7.PubMedCrossRefGoogle Scholar
  35. 35.
    Kleer C, Giordano T, Braun T, Oberman H. Pathologic, immunohistochemical and molecular features of benign and malignant phyllodes tumors of the breast. Mod Pathol. 2001;14:185–90.PubMedCrossRefGoogle Scholar
  36. 36.
    Soumarova R, Seneklova Z, Horova H, et al. Retrospective analysis of 25 women with malignant cystosarcoma phyllodes—treatment results. Arch Gynecol Obstet. 2004;269:278–81.PubMedCrossRefGoogle Scholar
  37. 37.
    Rissanen P, Holsti P. A retrospective study of sarcoma of the breast. Oncology. 1968;22:258–68.PubMedCrossRefGoogle Scholar
  38. 38.
    Chatson G, Anderson C, Berman M, et al. Phyllodes tumors. Contemp Surg. 1992;40:36–41.Google Scholar
  39. 39.
    Chaney A, Pollack A, McNeese M, Zagars G. Adjuvant radiation therapy for phyllodes tumors of the breast. Radiat Oncol Investig. 1998;6:264–7.PubMedCrossRefGoogle Scholar
  40. 40.
    Tan P, Jayabaskar T, Chuah K, et al. Phyllodes tumors of the breast, the role of pathologic parameters. Am J Clin Pathol. 2005;123:529.PubMedCrossRefGoogle Scholar
  41. 41.
    Vicini F, Beitsch P, Quiet C, et al. Three year analysis of treatment efficacy, cosmesis and toxicity in the American Society of Breast Surgeons Mammosite Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation. Cancer. 2008;112:758–66.PubMedCrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2009

Authors and Affiliations

  • Richard J. BarthJr.
    • 1
  • Wendy A. Wells
    • 2
  • Sandra E. Mitchell
    • 3
  • Bernard F. Cole
    • 4
  1. 1.Department of Surgery, Section of General SurgeryDartmouth-Hitchcock Medical CenterLebanonUSA
  2. 2.Department of PathologyDartmouth-Hitchcock Medical CenterLebanonUSA
  3. 3.Department of Radiation OncologyRandolph Cancer CenterAsheboroUSA
  4. 4.Department of Mathematics and StatisticsUniversity of VermontBurlingtonUSA

Personalised recommendations